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Abstract: Thrombocytopenia in critically ill patients probably reflects the severity of the 
underlying illness and these patients have a higher mortality due to the severity of overall 
clinical status. In present article we report a case of acute subdural hematoma who 
developed progressive thrombocytopenia resulting in fatal outcome. A 75 year 
gentleman presented with history of sudden onset headache and lapsed into altered 
sensorium. There was history of trivial fall before he developed headache. The patient 
was deeply comatose with pupils bilateral 2 mm and reacting to light. Computerized 
tomography (CT) scan brain showed large right fronto-temporo-parietal acute subdural 
hematoma with mass effect and midline shift. Post-operatively he was kept on elective 
ventilation. On following days the patient continues to develop thrombocytopenia (Day-
3 Platelet count 75,000, day-4 60,000, day-5 25,000). Thrombocytopenia is a common 
but a potentially life-threatening condition problem and has been considered to play a 
role in worsening the prognosis of critically ill patients in intensive care unit.  Few studies 
statistically examine the strength of the association between risk factors and outcomes 
related to thrombocytopenia, additional research is recommended to identify putative 
molecular determinants. 
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Introduction 
Thrombocytopenia is a common but a 
potentially life-threatening condition problem 
and has been considered to play a role in 
worsening the prognosis of critically ill 
patients in intensive care unit.  (1, 2)  
In present article we report a case of acute 
subdural hematoma who developed 
progressive thrombocytopenia resulting in 
fatal outcome.  
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Case report 
A 75 year gentleman presented with history 
of sudden onset headache and lapsed into 
altered sensorium. He was in altered 
sensorium since then. He was a known 
hypertensive on regular medication. There 
was no history of diabetes. There was history 
of trivial fall before he developed headache. On 
examination in the emergency department 
pulse rate was 100/minute, blood pressure was 
150/100 mmHg, saturation was 82% on room 
air, chest examination bilateral crepitations. 
The patient was deeply comatose with pupils 
bilateral 2 mm and reacting reacting to light. 
Extraocular movements were full. Blood 
investigations including coagulation profile 
and platelet count (1,65,000/mm3) were 
normal. Computerized tomography (CT) scan 
brain showed large right fronto-temporo-
parietal acute subdural hematoma with mass 
effect and midline shift. Post-operatively he 
was kept on elective ventilation. On following 
days the patient continues to develop 
thrombocytopenia (Day-3 Platelet count 
75,000, day-4 60,000, day-5 25,000). The 
patient febrile (102oF) but there was no clinical 
evidence of bleeding. Coagulation profile was 
normal.  Then antibiotics were changed and 
platelet count was marginally improved (Day-
6 60,000, day-7 1,00,000). However there was 
no improvement in general condition. 
Peripheral smear was normal except mild 
thrombocytopenia. The patient did not 
improve and expired on 10th day post injury. 
Discussion 
The mechanism of isolated 
thrombocytopenia in septicemia is largely 
unknown, (3) several mechanisms including 
compensated disseminated intravascular 
coagulation, (4) increased platelet destruction, 
(5) or some impairment of platelet production 
(6) have been proposed as the possible causes. 
Septicemia, have been identified as the major 
independent risk factor for thrombocytopenia 
(2, 7-9) as thrombocytopenia can occur early 
in the course of septicemia even before the 
pathogen is cultured from the blood. 10 
Platelet counts are measured just as frequently 
as hemoglobin, in the critical care unit, still 
platelet counts have not been well studied 
among critically ill patients. (3) 
Thrombocytopenia may occur in patients with 
septicemia without laboratory evidence of 
disturbed coagulation profile. (10-12) Validity 
of platelet count as a predictor of bleeding and 
correction of thrombocytopenia with platelet 
transfusions, is uncertain, (3) as major 
bleeding has not been defined consistently 
across studies. (13, 14) Just on the basis of 
laboratory findings alone, replacement 
therapy is not recommended and is required 
only in patients who are actively bleeding, who 
require an invasive procedure, or who are at 
risk for bleeding complications. (2, 15)  
Conclusion 
Thrombocytopenia in critically ill patients 
probably reflects the severity of the underlying 
illness and these patients have a higher mortality 
due to the severity of overall clinical status. (3, 16-
19) Few studies statistically examine the strength 
of the association between risk factors and 
outcomes related to thrombocytopenia, (3) 
additional research is recommended to identify 
putative molecular determinants and patho-
genetic mechanisms causing isolated 
thrombocytopenia in critically ill patients 
because of septicemia. (20) 
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